Can your insurance records prove a drug works? scientists test the idea
NCT ID NCT06659744
Summary
This study did not give any medicine to participants. Instead, researchers used health insurance records from over 150,000 people with type 2 diabetes to see if real-world data can confirm the heart safety results of a previous major trial. That trial found the injectable diabetes drug semaglutide reduced the risk of major heart problems. The goal is to learn when and how real-world data can reliably answer medical questions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.